Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Walcher

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Coronary Artery Disease|June 1, 2016
Clinical results of single and multiple bioresorbable drug-eluting scaffolds for treatment of de-novo coronary artery diseaseSinisa Markovic, Sergiu Dragomir, Daniel Walcher, et al.
Molecular and Cellular Endocrinology|January 25, 2012
C-peptide induces human renal mesangial cell proliferation in vitro, activating Src-kinase, PI-3 kinase and ERK1/2Dusica Vasic, Andreas Spyrantis, Renate Durst, et al.
European Journal of Radiology|August 6, 2010
Detection of long-term progression of myocardial fibrosis in Duchenne muscular dystrophy in an affected family: a cardiovascular magnetic resonance studyThomas Walcher, Peter Steinbach, Jochen Spiess, et al.
Mediators of Inflammation|December 29, 2010
Ivabradine reduces chemokine-induced CD4-positive lymphocyte migrationThomas Walcher, Peter Bernhardt, Dusica Vasic, et al.
Journal of the American College of Cardiology|October 2, 2010
Neoplastic pericardial effusion induces functional nonvalvular mitral valve stenosisPeter Bernhardt, Armin Imhof, Johannes Schwaab, et al.
Journal of the American College of Cardiology|June 21, 2005
Improvement of cardiovascular risk markers by pioglitazone is independent from glycemic control: results from the pioneer studyAndreas Pfützner, Nikolaus Marx, Georg Lübben, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 18, 2006
LXR activation reduces proinflammatory cytokine expression in human CD4-positive lymphocytesDaniel Walcher, Andreas Kümmel, Bettina Kehrle, et al.
International Journal of Cardiology|November 3, 2009
Blood oxygen level-dependent magnetic resonance imaging using T2-prepared steady-state free-precession imaging in comparison to contrast-enhanced myocardial perfusion imagingPeter Bernhardt, Robert Manzke, Axel Bornstedt, et al.
Basic Research in Cardiology|April 6, 2010
LXR activation inhibits chemokine-induced CD4-positive lymphocyte migrationDaniel Walcher, Dusica Vasic, Philipp Heinz, et al.
The Journal of Invasive Cardiology|April 4, 2017
Percutaneous Mitral Valve Repair With the MitraClip in Primary Compared With Secondary Mitral Valve Regurgitation Using the Mitral Valve Academic Research Consortium CriteriaJulia Seeger, Patrick Müller, Birgid Gonska, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Coronary Artery Disease|June 1, 2016
Clinical results of single and multiple bioresorbable drug-eluting scaffolds for treatment of de-novo coronary artery diseaseSinisa Markovic, Sergiu Dragomir, Daniel Walcher, et al.
Molecular and Cellular Endocrinology|January 25, 2012
C-peptide induces human renal mesangial cell proliferation in vitro, activating Src-kinase, PI-3 kinase and ERK1/2Dusica Vasic, Andreas Spyrantis, Renate Durst, et al.
European Journal of Radiology|August 6, 2010
Detection of long-term progression of myocardial fibrosis in Duchenne muscular dystrophy in an affected family: a cardiovascular magnetic resonance studyThomas Walcher, Peter Steinbach, Jochen Spiess, et al.
Mediators of Inflammation|December 29, 2010
Ivabradine reduces chemokine-induced CD4-positive lymphocyte migrationThomas Walcher, Peter Bernhardt, Dusica Vasic, et al.
Journal of the American College of Cardiology|October 2, 2010
Neoplastic pericardial effusion induces functional nonvalvular mitral valve stenosisPeter Bernhardt, Armin Imhof, Johannes Schwaab, et al.
Journal of the American College of Cardiology|June 21, 2005
Improvement of cardiovascular risk markers by pioglitazone is independent from glycemic control: results from the pioneer studyAndreas Pfützner, Nikolaus Marx, Georg Lübben, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 18, 2006
LXR activation reduces proinflammatory cytokine expression in human CD4-positive lymphocytesDaniel Walcher, Andreas Kümmel, Bettina Kehrle, et al.
International Journal of Cardiology|November 3, 2009
Blood oxygen level-dependent magnetic resonance imaging using T2-prepared steady-state free-precession imaging in comparison to contrast-enhanced myocardial perfusion imagingPeter Bernhardt, Robert Manzke, Axel Bornstedt, et al.
Basic Research in Cardiology|April 6, 2010
LXR activation inhibits chemokine-induced CD4-positive lymphocyte migrationDaniel Walcher, Dusica Vasic, Philipp Heinz, et al.
The Journal of Invasive Cardiology|April 4, 2017
Percutaneous Mitral Valve Repair With the MitraClip in Primary Compared With Secondary Mitral Valve Regurgitation Using the Mitral Valve Academic Research Consortium CriteriaJulia Seeger, Patrick Müller, Birgid Gonska, et al.
Pageof 4